Skip to content

Nasya treatment in migrain

A Comparative study on the effect of balahatadi tail nasya with and without priyala kharjooradi yog(kalpit) in ardhaavbhedhaka W.S.R to migraine

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042560
Enrollment
30
Registered
2022-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

None listed

Sponsors

Self Dr Sakshi Saroch
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (1)Patient wiling for study. (2)Patient with classical lakshan of Ardhavbhedak/migrain. (3)Patient of age between 16-60yrs irrespective of sex,religion and occupation will be selected fir study. (4)Patient fit for Nasya karma

Exclusion criteria

Exclusion criteria: (1)Patient not willing for study. (2)Patient suffering from any other forms of headache apart from Ardhavbhedak. (3) Headaches secondary to medical conditions like Meningitis,Tumor, encephalitis,spondylosis or any other intracranial lesions and refractive errors etc. (4)Patients with complications of Migrain e.g.status migrainosus,migrain aura triggered seizure,probable migraine etc. (5)Patients who are contraindicated for Nasya karma

Design outcomes

Primary

MeasureTime frame
Clinical symptoms will be assessed depending on severity of 1) Headache(half sided pain) 2) Frequency of headache 3) Duration of headache 4) Nausea 5) Vomiting 6) Vertigo 7) Aura For example, For Duration of headache, scoring will be done like Nil-0 1-3 hours/day-1 3-6 hours/day-2 6-12 hours/day-3 More than 12 hours/day -4Timepoint: 30 days

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Sakshi saroch

Dayanand Ayurveda college Jalandhar affiliated to Guru Ravidas University Hoshiarpur Punjab

drsanjeevsood@yahoo.com9814004142

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026